Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.79 - $1.14 $8,625 - $12,446
-10,918 Reduced 41.55%
15,358 $14,000
Q4 2023

Feb 14, 2024

SELL
$1.02 - $2.57 $1,227 - $3,091
-1,203 Reduced 4.38%
26,276 $28,000
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $11,322 - $25,565
4,493 Added 19.55%
27,479 $70,000
Q2 2023

Aug 14, 2023

BUY
$5.0 - $7.66 $114,930 - $176,072
22,986 New
22,986 $124,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.